BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 8188003)

  • 1. [Anatomopathological lesions in chronic hepatitis related to C virus: necessity of a consensus?].
    Emile JF
    Gastroenterol Clin Biol; 1994; 18(1):98-100. PubMed ID: 8188003
    [No Abstract]   [Full Text] [Related]  

  • 2. [Hepatitis C virus, interferon alpha, and dysthyroidism].
    Marcellin P; Pouteau M; Messian O; Bok B; Erlinger S; Benhamou JP
    Gastroenterol Clin Biol; 1993; 17(12):887-91. PubMed ID: 8125219
    [No Abstract]   [Full Text] [Related]  

  • 3. Further inquiry into treating hepatitis C with recombinant interferon alpha.
    Puoti C; Fuiano B; Annovazzi G; Pannullo A; Patane F
    Ital J Gastroenterol; 1992 Feb; 24(2):111. PubMed ID: 1576363
    [No Abstract]   [Full Text] [Related]  

  • 4. [Treatment of chronic viral hepatitis].
    Marcellin P; Metreau JM; Pol S; Zoulim F
    Ann Gastroenterol Hepatol (Paris); 1996; 32(2):85-7. PubMed ID: 8737503
    [No Abstract]   [Full Text] [Related]  

  • 5. [Hepatitis A, B, C and D. Pathological anatomy].
    Voigt JJ; Degott C
    Rev Prat; 1993 Sep; 43(14):1857-8. PubMed ID: 8310233
    [No Abstract]   [Full Text] [Related]  

  • 6. [Etiological treatment of cirrhosis in adults].
    Doffoël M; Gabanyi J; Vetter D
    Rev Prat; 1997 Mar; 47(5):503-6. PubMed ID: 9138412
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extrahepatic manifestations of chronic viral hepatitis.
    Willson RA
    Am J Gastroenterol; 1997 Jan; 92(1):3-17. PubMed ID: 8995930
    [No Abstract]   [Full Text] [Related]  

  • 8. Limited benefits of INF-alpha therapy in renal graft candidates with chronic viral hepatitis B or C.
    Rodrigues A; Morgado T; Areias J; Silvestre F; Pinho L; Alves H; Castro-Henriques A; Sarmento A; Guimarães S
    Transplant Proc; 1997; 29(1-2):777-80. PubMed ID: 9123522
    [No Abstract]   [Full Text] [Related]  

  • 9. [How to follow treated and untreated chronic hepatitis B and C].
    Adler M; Golstein P; Botembe N; Bourgeois N
    Rev Med Brux; 1997 Sep; 18(4):183-6. PubMed ID: 9411639
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Lichen planus and hepatitis C virus. Apropos of 5 new cases].
    Hyrailles V; Peyron N; Blanc P; Mark Y; Meunier L; Meynadier J; Larrey D; Michel H
    Gastroenterol Clin Biol; 1995 Oct; 19(10):833-6. PubMed ID: 8566564
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The treatment of chronic viral hepatitis B/D and acute and chronic viral hepatitis C. The consensus of the German Society for Digestive and Metabolic Diseases].
    Hopf U; Niederau C; Kleber G; Fleig WE
    Z Gastroenterol; 1997 Nov; 35(11):971-86. PubMed ID: 9490556
    [No Abstract]   [Full Text] [Related]  

  • 12. Epidemiology of hepatocellular carcinoma. Evaluation of viral and other risk factors in a low-endemic area for hepatitis B and C.
    Peters M; Wellek S; Dienes HP; Junginger T; Meyer J; Meyer Zum Büschendfelde KH; Gerken G
    Z Gastroenterol; 1994 Mar; 32(3):146-51. PubMed ID: 8197809
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Therapy of chronic hepatitis B, C and D with alpha-interferon].
    Niederau C
    Fortschr Med; 1993 Feb; 111(6):35-7. PubMed ID: 8462911
    [No Abstract]   [Full Text] [Related]  

  • 14. [Organic nephropathies in patients with liver diseases].
    Amoedo ML; Montoliu J
    Gastroenterol Hepatol; 1996 Mar; 19(3):167-77. PubMed ID: 8991663
    [No Abstract]   [Full Text] [Related]  

  • 15. [Interferon-alpha in the treatment of chronic viral hepatitis].
    Melman ML
    Rev Gastroenterol Mex; 1994; 59(2 Suppl):46-8. PubMed ID: 8091094
    [No Abstract]   [Full Text] [Related]  

  • 16. Morphometric assessment of nucleolar activity in liver cells during the evolutive pathway of chronic hepatitis C to cirrhosis.
    Betta PG; Robutti F; Fruttaldo L; Pavesi M; Pastormerlo M; Tallarida F
    Pathologica; 1993; 85(1095):31-6. PubMed ID: 8516024
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Liver transplantation in patients with cirrhosis secondary to hepatitis B virus and hepatitis C virus infections].
    Lucena JF; Herrero JI
    An Sist Sanit Navar; 2004; 27 Suppl 2():91-101. PubMed ID: 15381947
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successful antiviral therapy and prognosis in cirrhosis due to hepatitis B.
    Han SB; Martin P
    Am J Gastroenterol; 1998 Jun; 93(6):859-60. PubMed ID: 9647008
    [No Abstract]   [Full Text] [Related]  

  • 19. [What are the indications for interferon therapy with regard to the significance of serologic and histologic findings and laboratory data?].
    Gerken G
    Internist (Berl); 1993 Nov; 34(11):1062-5. PubMed ID: 8282492
    [No Abstract]   [Full Text] [Related]  

  • 20. Serum hyaluronate predicts response to interferon-alpha therapy in patients with chronic hepatitis C.
    Ueno T; Inuzuka S; Sata M; Koh H; Tamaki S; Kin M; Sugawara H; Sakata R; Torimura T; Tanikawa K
    Hepatogastroenterology; 1995; 42(5):522-7. PubMed ID: 8751209
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.